ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Information for professionals for Fluo-calc®:MEDA Pharma GmbH
Complete information for professionalsDDDPrint 
Galenic Form / Therapeutic GroupComposition.EffectsPharm.kinetikIndication.UsageRestrictions.Unwanted effects
Interactions.OverdoseOther adviceSwissmedic-Nr.Last update of information 
A12CD51 - Fluoride, CombinationsATC-DDD Version 2016. Source: WHO
A - Alimentary Tract and Metabolism
 
A12 - Mineral Supplements

This group contains mineral supplements used for treatment of mineral deficiency. All parenteral solutions of electrolytes are classified in B05B or in B05X. Magnesium carbonate used for treatment of mineral deficiency is classified in A02AA01.

A12C - Other Mineral Supplements

This group comprises other minerals.
See also B05 - Blood substitutes and perfusion solutions.

A12CD - Fluoride

This group comprises preparations used e.g. in the treatment of osteoporosis. Fluoride used in caries prophylaxis, see A01AA - Caries prophylatic agents.
Bisphosphonates are classified in M05B.
Calcitonin is classified in H05BA.
Calcium preparations are classified in A12A.
Combinations with calcium are classified here.

The DDD is based on treatment of osteoporosis.

A12CD51 - Fluoride, Combinations
2024 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home